PRMT5 and colorectal carcinoma: As bioinformatic analyses revealed that PRMT5 expression was higher in patients unresponsive to CPT‐11 chemotherapy, the correlation between PRMT5 expression and CPT‐11 sensitivity in MSS CRC cell lines was evaluated.